{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:18:57Z","timestamp":1778494737610,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"am","delay-in-days":405,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR200045"],"award-info":[{"award-number":["RR200045"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA101642"],"award-info":[{"award-number":["CA101642"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ygyno.2025.01.011","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T17:02:35Z","timestamp":1744304555000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An inducible FOXL2-dependent mouse model of ovarian adult type granulosa cell tumor"],"prefix":"10.1016","volume":"194","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Calzoncinth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena K.","family":"Vuttaradhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison L.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwong-Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu M.","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barrett","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles V.","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Tyler","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.01.011_bb0005","first-page":"1180","article-title":"Granulosa cell tumor of the ovary","volume":"21","author":"Schumer","year":"2003","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0010","first-page":"3495","article-title":"Adult-type granulosa cell tumor of the ovary","volume":"12","author":"Li","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2021.07.024","article-title":"PARAGON investigators, a phase 2 study of anastrozole in patients with oestrogen receptor and\/progesterone receptor positive recurrent\/metastatic granulosa cell tumours\/sex-cord stromal tumours of the ovary: the PARAGON\/ANZGOG 0903 trial","volume":"163","author":"Banerjee","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0020","first-page":"1","article-title":"Effect of weekly paclitaxel with or without bevacizumab on progression-free rate among patients with relapsed ovarian sex cord-stromal tumors: the ALIENOR\/ENGOT-ov7 randomized clinical trial","author":"Ray-Coquard","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2024.09.002","article-title":"Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: an NRG oncology\/gynecologic oncology group study14","volume":"190","author":"Brown","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0030","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in granulosa-cell tumors of the ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1242\/dev.00969","article-title":"The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance","volume":"131","author":"Schmidt","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.ygyno.2025.01.011_bb0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddh124","article-title":"Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development","volume":"13","author":"Uda","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1471-0528.13949","article-title":"Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study","volume":"124","author":"Bryk","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2025.01.011_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/360313a0","article-title":"\u0391-lnhibin is a tumour-suppressor gene with gonadal specificity in mice","volume":"360","author":"Matzuk","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2025.01.011_bb0055","first-page":"616","article-title":"Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter\/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines","volume":"9","author":"Kananen","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0060","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1158\/0008-5472.CAN-05-1024","article-title":"Misregulated Wnt\/beta-catenin signaling leads to ovarian granulosa cell tumor development","volume":"65","author":"Boerboom","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1210\/en.2014-1926","article-title":"Cell autonomous phosphoinositide 3-kinase activation in oocytes disrupts normal ovarian function through promoting survival and overgrowth of ovarian follicles","volume":"156","author":"Kim","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2025.01.011_bb0070","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/carcin\/bgn186","article-title":"Synergistic effects of Pten loss and WNT\/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression","volume":"29","author":"Lagu\u00eb","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2025.01.011_bb0075","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41467-018-04950-x","article-title":"KMT2D\/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary","volume":"9","author":"Hillman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ygyno.2021.06.024","article-title":"Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors","volume":"162","author":"Hillman","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/MCB.01404-07","article-title":"Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice","volume":"28","author":"Pangas","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0090","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1210\/me.2009-0461","article-title":"Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development","volume":"24","author":"Edson","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1158\/0008-5472.CAN-22-1880","article-title":"The oncogenic FOXL2 C134W mutation is a key driver of granulosa cell tumors","volume":"83","author":"Llano","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nbt811","article-title":"A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse","volume":"21","author":"Schn\u00fctgen","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ng1003","article-title":"Requirement of Bmpr1a for M\u00fcllerian duct regression during male sexual development","volume":"32","author":"Jamin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0110","doi-asserted-by":"crossref","first-page":"20678","DOI":"10.1038\/s41598-020-77666-y","article-title":"Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations","volume":"10","author":"Kun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2025.01.011_bb0115","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/cam4.445","article-title":"An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations","volume":"4","author":"Yang","year":"2015","journal-title":"Cancer Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:13Z","timestamp":1777474693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582500023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"alternative-id":["S009082582500023X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An inducible FOXL2-dependent mouse model of ovarian adult type granulosa cell tumor","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}